| |
|
|
| Name: |
Deep Track Capital LP |
| City: |
GREENWICH |
| State: |
CT |
| Zip: |
06830 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
77 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ITCI |
Intra Cellular Therapies Inc |
1 |
- |
$131.87 |
$263,840,000 |
2,000,000 |
8.54% |
96,800,000 |
0 |
2.118 |
N/A |
|
|
GH |
Guardant Health, Inc. |
2 |
- |
$0.00 |
$231,903,000 |
5,443,721 |
7.51% |
35,785,000 |
-975,845 |
4.187 |
N/A |
|
|
DVAX |
Dynavax Technologies Corp |
3 |
- |
$10.27 |
$230,756,000 |
17,791,486 |
7.47% |
3,559,000 |
0 |
13.204 |
Drug Manufacturers - ... |
|
|
IMVT |
Immunovant Inc |
4 |
- |
$0.00 |
$162,355,000 |
9,500,000 |
5.26% |
13,735,000 |
3,500,000 |
10.91 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
5 |
- |
$51.05 |
$145,080,000 |
3,000,000 |
4.7% |
106,480,000 |
2,000,000 |
4.692 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
6 |
- |
$43.00 |
$137,702,000 |
4,564,207 |
4.46% |
70,092,000 |
2,630,279 |
2.889 |
Drug Manufacturers - ... |
|
|
AKRO |
Akero Therapeutics, Inc. |
7 |
- |
$0.00 |
$129,952,000 |
3,210,270 |
4.21% |
88,500,000 |
1,720,270 |
4.256 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
8 |
- |
$34.66 |
$123,538,000 |
3,073,853 |
4% |
5,938,000 |
573,853 |
2.239 |
Biotechnology |
|
|
APLS |
Apellis Pharmaceuticals Inc |
9 |
- |
$18.26 |
$109,350,000 |
5,000,000 |
3.54% |
-27,063,000 |
725,079 |
4.032 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
10 |
- |
$0.00 |
$104,778,000 |
14,294,420 |
3.39% |
-4,844,000 |
1,458,138 |
9.168 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
11 |
- |
$43.99 |
$96,796,000 |
2,800,000 |
3.13% |
74,318,000 |
1,980,838 |
1.609 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
12 |
New |
$0.00 |
$76,247,000 |
1,484,266 |
2.47% |
76,247,000 |
1,484,266 |
3.351 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
13 |
- |
$15.67 |
$72,528,000 |
5,380,449 |
2.35% |
-14,173,000 |
857,708 |
5.978 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
14 |
- |
$20.37 |
$70,971,000 |
4,100,000 |
2.3% |
-4,965,000 |
1,300,000 |
6.508 |
N/A |
|
|
ETNB |
89bio, Inc. |
15 |
- |
$10.16 |
$67,730,000 |
9,316,333 |
2.19% |
17,070,000 |
2,838,084 |
8.796 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
16 |
- |
$0.00 |
$65,340,000 |
5,500,000 |
2.12% |
8,820,000 |
2,500,000 |
7.746 |
N/A |
|
|
GERN |
Geron Corporation |
17 |
- |
$1.43 |
$60,700,000 |
38,176,251 |
1.97% |
46,500,000 |
34,164,964 |
7.03 |
Drug Manufacturers - ... |
|
|
SRPT |
Sarepta Therapeutics Inc |
18 |
New |
$18.24 |
$57,421,000 |
899,731 |
1.86% |
57,421,000 |
899,731 |
0.943 |
Drug Manufacturers - ... |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
19 |
- |
$39.91 |
$48,884,000 |
1,350,000 |
1.58% |
21,391,000 |
696,487 |
1.466 |
Restaurants |
|
|
ANIP |
ANI Pharmaceuticals Inc |
20 |
- |
$67.25 |
$46,865,000 |
700,000 |
1.52% |
10,986,000 |
50,958 |
3.426 |
Biotechnology |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
21 |
New |
$0.70 |
$42,769,000 |
2,357,702 |
1.38% |
42,769,000 |
2,357,702 |
7.254 |
N/A |
|
|
IMCR |
Immunocore Holdings Adr |
22 |
- |
$33.02 |
$41,876,000 |
1,411,402 |
1.36% |
26,554,000 |
892,026 |
2.823 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
23 |
- |
$22.00 |
$36,300,000 |
2,000,000 |
1.18% |
-2,619,000 |
459,868 |
2.711 |
Diagnostic Substances |
|
|
MAZE |
Maze Therapeutics, Inc. |
24 |
New |
$11.50 |
$35,993,000 |
3,269,126 |
1.17% |
35,993,000 |
3,269,126 |
7.464 |
N/A |
|
|
AMGN |
Amgen Inc |
25 |
New |
$298.24 |
$35,216,000 |
113,035 |
1.14% |
35,216,000 |
113,035 |
0.019 |
Biotechnology |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
26 |
- |
$0.00 |
$33,550,000 |
1,000,000 |
1.09% |
26,920,000 |
830,868 |
1.328 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
27 |
- |
$13.03 |
$30,800,000 |
1,400,000 |
1% |
11,832,000 |
689,579 |
1.357 |
N/A |
|
|
MTSR |
Metsera, Inc. |
28 |
New |
$29.45 |
$29,790,000 |
1,094,408 |
0.96% |
29,790,000 |
1,094,408 |
1.042 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
29 |
New |
$0.00 |
$28,320,000 |
750,000 |
0.92% |
28,320,000 |
750,000 |
0.549 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
30 |
- |
$2.37 |
$27,667,000 |
17,849,482 |
0.9% |
-5,747,000 |
3,630,579 |
6.708 |
N/A |
|
|
BCAX |
Bicara Therapeutics Inc. |
31 |
- |
$9.03 |
$26,060,000 |
2,000,000 |
0.84% |
-8,780,000 |
0 |
3.677 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
32 |
New |
$0.00 |
$25,339,000 |
8,859,648 |
0.82% |
25,339,000 |
8,859,648 |
25.451 |
N/A |
|
|
TECX |
Tectonic Therapeutic Inc |
33 |
New |
$21.34 |
$24,828,000 |
1,401,938 |
0.8% |
24,828,000 |
1,401,938 |
9.518 |
N/A |
|
|
ABVX |
Abivax S.A |
34 |
- |
$7.96 |
$22,370,000 |
3,579,209 |
0.72% |
-3,830,000 |
0 |
5.773 |
N/A |
|
|
MBX |
Mbx Biosciences, Inc. |
35 |
- |
$0.00 |
$22,280,000 |
3,018,935 |
0.72% |
-33,359,000 |
0 |
9.033 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
36 |
New |
$0.00 |
$22,060,000 |
2,000,000 |
0.71% |
22,060,000 |
2,000,000 |
4.094 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
37 |
- |
$8.76 |
$20,920,000 |
2,000,000 |
0.68% |
-26,200,000 |
0 |
1.733 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
38 |
- |
$3.80 |
$20,418,000 |
4,557,575 |
0.66% |
-9,890,000 |
0 |
10.318 |
N/A |
|
|
INSM |
Insmed Inc |
39 |
New |
$97.80 |
$19,435,000 |
254,751 |
0.63% |
19,435,000 |
254,751 |
0.134 |
Biotechnology |
|
|
GLPG |
Galapagos NV - ADR |
40 |
- |
$28.83 |
$18,616,000 |
741,068 |
0.6% |
-2,855,000 |
-39,710 |
1.134 |
N/A |
|
|
SAGE |
Sage Therapeutics, Inc. |
41 |
New |
$0.00 |
$16,209,000 |
2,038,845 |
0.52% |
16,209,000 |
2,038,845 |
3.498 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
42 |
- |
$4.32 |
$15,391,000 |
5,576,558 |
0.5% |
-15,503,000 |
0 |
6.639 |
N/A |
|
|
KRRO |
Korro Bio |
43 |
- |
$0.00 |
$15,227,000 |
874,614 |
0.49% |
-18,070,000 |
0 |
2.599 |
N/A |
|
|
ORKA |
Oruka Therapeutics, Inc |
44 |
- |
$12.60 |
$14,823,000 |
1,444,709 |
0.48% |
280,000 |
694,709 |
4.128 |
Diagnostic Substances |
|
|
MNMD |
Mind Medicine |
45 |
- |
$7.17 |
$14,625,000 |
2,500,000 |
0.47% |
-4,978,000 |
-316,594 |
3.07 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
46 |
- |
$11.20 |
$14,073,000 |
2,299,567 |
0.46% |
-2,367,000 |
1,299,567 |
4.339 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
47 |
- |
$0.00 |
$12,945,000 |
3,442,833 |
0.42% |
-7,127,000 |
0 |
5.729 |
N/A |
|
|
SEPN |
Septerna, Inc. |
48 |
- |
$11.37 |
$11,076,000 |
1,912,929 |
0.36% |
-32,730,000 |
0 |
4.308 |
N/A |
|
|
NVAX |
Novavax Inc |
49 |
- |
$0.36 |
$9,732,000 |
1,518,182 |
0.32% |
-6,348,000 |
-481,818 |
1.278 |
Biotechnology |
|
|
CYBN |
Cybin Inc |
50 |
- |
$7.94 |
$9,700,000 |
1,529,987 |
0.31% |
-3,794,000 |
0 |
0.17 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
51 |
- |
$1.03 |
$7,334,000 |
6,011,380 |
0.24% |
-2,164,000 |
0 |
16.649 |
N/A |
|
|
PLRX |
Pliant Therapeutics, Inc. |
52 |
- |
$0.00 |
$7,290,000 |
5,399,681 |
0.24% |
-71,365,000 |
-572,576 |
7.848 |
N/A |
|
|
AVTX |
Avalo Therapeutics, Inc |
53 |
- |
$0.43 |
$6,888,000 |
859,876 |
0.22% |
446,000 |
-7,124 |
0.766 |
N/A |
|
|
BCYC |
Bicycle Therapeutics Ltd |
54 |
- |
$0.00 |
$6,512,000 |
767,016 |
0.21% |
-11,353,000 |
-509,065 |
1.112 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
55 |
New |
$20.01 |
$6,167,000 |
315,765 |
0.2% |
6,167,000 |
315,765 |
0.387 |
N/A |
|
|
ADGI |
Adagio Therapeutics, Inc. |
56 |
- |
$0.74 |
$5,885,000 |
9,722,254 |
0.19% |
1,148,000 |
-967,349 |
8.739 |
N/A |
|
|
XNCR |
Xencor Inc |
57 |
- |
$8.42 |
$5,846,000 |
549,439 |
0.19% |
-5,644,000 |
49,439 |
0.61 |
Biotechnology |
|
|
RGLS |
Regulus Therapeutics Inc. |
58 |
- |
$8.16 |
$5,709,000 |
3,262,564 |
0.18% |
554,000 |
0 |
2.235 |
Biotechnology |
|
|
INO |
Inovio Biomedical Corp |
59 |
- |
$0.58 |
$5,084,000 |
3,119,162 |
0.16% |
-624,000 |
0 |
1.841 |
Medical Instruments &... |
|
|
RAPP |
Rapport Therapeutics, Inc. |
60 |
New |
$12.04 |
$4,589,000 |
457,556 |
0.15% |
4,589,000 |
457,556 |
1.251 |
N/A |
|
|
CNTX |
Context Therapeutics Inc. |
61 |
- |
$0.00 |
$4,541,000 |
7,419,355 |
0.15% |
-3,249,000 |
0 |
9.892 |
N/A |
|
|
ZURA |
Zura Bio Ltd |
62 |
- |
$1.13 |
$4,236,000 |
3,283,783 |
0.14% |
-3,973,000 |
0 |
5.195 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
63 |
- |
$0.00 |
$3,664,000 |
444,110 |
0.12% |
-6,061,000 |
200,000 |
0.617 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
64 |
- |
$0.60 |
$3,534,000 |
219,015 |
0.11% |
-1,565,000 |
0 |
0.358 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
65 |
New |
$0.00 |
$3,220,000 |
2,515,513 |
0.1% |
3,220,000 |
2,515,513 |
5.212 |
N/A |
|
|
OKUR |
OnKure Therapeutics, Inc. |
66 |
- |
$2.38 |
$2,253,000 |
523,989 |
0.07% |
-2,253,000 |
0 |
4.142 |
N/A |
|
|
ALLK |
Allakos Inc. |
67 |
- |
$0.33 |
$1,646,000 |
7,232,701 |
0.05% |
-5,256,000 |
1,528,419 |
8.488 |
N/A |
|
|
NGNE |
Neurogene |
68 |
New |
$3.68 |
$1,366,000 |
116,660 |
0.04% |
1,366,000 |
116,660 |
0.278 |
N/A |
|
|
ELYM |
Eliem Therapeutics, Inc. |
69 |
- |
$0.00 |
$1,269,000 |
1,040,115 |
0.04% |
-603,000 |
0 |
1.551 |
N/A |
|
|
GMXAY |
GENMAB AS |
73 |
Closed |
$20.30 |
$0 |
0 |
0% |
-41,740,000 |
-2,000,000 |
0 |
N/A |
|
|
SWTX |
Springworks Therapeutics, Inc. |
72 |
Closed |
$0.00 |
$0 |
0 |
0% |
-125,037,000 |
-3,460,756 |
0 |
N/A |
|
|
HRMY |
Harmony Biosciences Holding... |
71 |
Closed |
$0.00 |
$0 |
0 |
0% |
-49,895,000 |
-1,450,000 |
0 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
77 |
Closed |
$0.00 |
$0 |
0 |
0% |
-39,474,000 |
-850,000 |
0 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
70 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,397,000 |
-609,900 |
0 |
N/A |
|
|
NMRA |
Neumora Therapeutics, Inc. |
76 |
Closed |
$0.82 |
$0 |
0 |
0% |
-42,400,000 |
-4,000,000 |
0 |
N/A |
|
|
NKTR |
Nektar Therapeutics |
75 |
Closed |
$0.67 |
$0 |
0 |
0% |
-1,838,000 |
-1,975,998 |
0 |
Drug Delivery |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
74 |
Closed |
$0.00 |
$0 |
0 |
0% |
-22,613,000 |
-1,350,000 |
0 |
N/A |
|
